Metraipolis › archive › dc_b2d28cc2d03b
Systems-level analyses and clinical validation highlight CD53 as a diagnostic and prognostic marker in lung adenocarcinoma — Europe PMC PMID:42368459
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42368459
- DOI
- 10.3389/fcell.2026.1806566
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-31T13:50:46.734Z
- SHA-256 of the archived text
a6f98d99a423e0d57e45439bd2685165b2d31be0355b89f9ebf804b888110927- Stable URL of this page
https://metraipolis.com/documento/dc_b2d28cc2d03b
How to cite
Systems-level analyses and clinical validation highlight CD53 as a diagnostic and prognostic marker in lung adenocarcinoma — Europe PMC PMID:42368459 — Europe PMC (en), https://europepmc.org/article/MED/42368459 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b2d28cc2d03b (Metraipolis archive dc_b2d28cc2d03b, sha256 a6f98d99a423e0d57e45439bd2685165b2d31be0355b89f9ebf804b888110927)
BibTeX
@misc{dcb2d28cc2d03b,
title = {Systems-level analyses and clinical validation highlight CD53 as a diagnostic and prognostic marker in lung adenocarcinoma — Europe PMC PMID:42368459},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42368459},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b2d28cc2d03b; sha256 a6f98d99a423e0d57e45439bd2685165b2d31be0355b89f9ebf804b888110927},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42368459. Agents can read the archived copy with the MCP tool read_document.